A class action lawsuit was filed against GeneDx Holdings on July 7, alleging misrepresentations regarding acquisition performance. The company's stock experienced a 49% decline during the period from April 2025 to May 2026. The lawsuit was filed by Bronstein, Gewirtz & Grossman, LLC, accusing the company of violating federal securities laws. The deadline for investors to apply for lead plaintiff status is August 3, 2026.
